![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Produktkate gorien
AlkoholismusAllergikerAlzheimer Und ParkinsonAnalgetikaAnti-depressivaAnti-virusAntibiotikaAntikonvulsivaAntiparasitenmittelAntipilzmittelAntzündungshemmende MittelArthritisAsthmaAtemwegeAugepflegeCholesterinDiabetesDiuretikaErektionsstörungenFettsuchtFrauenmedizinGesundheit Des MannesH I VHarnweg-traktHautpflegeHerz-kreislauf-erkrankungenHypertonieKrebsMagen-darm-traktMental-psychische StörungenMigräneMuskel-relaxansNeurologische StörungenOperationenOsteoporoseVerhütungsmittel 15 May 2012 20:12:30
Việc sá» dụng thuốc chống trầm cảmViá c sá dá ng thuá c chá ng trá m cá m VOA Tiá ng Viá t Nhá ng thuá c thÆ á ng gá p là fluoxetin (Prozac, Sarafem), sertralin (Zoloft), paroxetin (Paxil), fluvoxamin ( Luvox ). Theo khuyá n cà o hiá n nay cá a Tá chá c Y tá Quá c tá (WHO), là c chá a cÆ n trá m cá m bá ng thuá c, ná u thuá c hiá u nghiá m ngÆ á i ta cho bá nh nhà n ...
09 May 2012 16:58:15
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results Sacramento Bee Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:08:54
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results MarketWatch (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:07:12
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results PR Newswire (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
01 May 2012 01:43:07
Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ...Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ... MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
27 Apr 2012 13:24:36
Jazzed up for M&A, VCs Get a ReturnJazzed up for M&A, VCs Get a Return Private Equity Hub (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
26 Apr 2012 22:17:15
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA PharmaJazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
|
|
Choose Your language:
Site-Suche:
Unsere Kundenmeinungen
Ich habe meine Bestellung diese Woche erhalten. Vielen Dank. Glauben Sie mir, ich werde wieder Bestellen!!!!! Meine Frau war mehr als überrascht mit den Ergebnissen und für mich.... Ich fühlte mich wieder wie ein 18-Jähriger. Vielen, vielen Dank. Sie werden wieder von mir hören:) David
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|AGB|FAQ|Unsere Kundenmeinungen|Kontakt|Sitemap |
|
|
|
|
| |